GlobalGov › Spain › Solicitation

Spain – Pharmaceutical products – Suministro de la asociación de Pertuzumab (DOE) y Trastuzumab (DOE), Emicizumab (DOE), Faricimab (DOE), Glofitamab (DOE), Obinutuzumab (DOE) y Trastuzumab emtansina (DOE)

Osakidetza - Servicio Vasco De Salud - Organización Central · Spain government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

$110.3M
Est. Value
Active
Status

Opportunity Overview

L1_ASOCIACIÓN PERTUZUMAB (DOE)/TRASTUZUMAB (DOE) | L2_EMICIZUMAB (DOE) | L3_FARICIMAB (DOE) | L4_GLOFITAMAB (DOE) | L5_OBINUTUZUMAB (DOE) | L6_TRASTUZUMAB EMTANSINA (DOE)

This is one of 38 active Spain Pharmaceuticals opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyOsakidetza - Servicio Vasco De Salud - Organización Central
CountrySpain
CategoryPharmaceuticals
Estimated value$110.3M
PublishedAugust 14, 2026
Procurement stageRequest for Proposal (RFP)
Response dueNot specified / rolling
StatusOpen — accepting responses
TranslationTranslated from Spanish by GlobalGov’s translation pipeline
Official sourceView original notice
Last verifiedOctober 04, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Spain market overview →Browse all categories →

Related Opportunities in Spain

Spain – Pharmaceutical products – Suministro de Apalutamida(DOE), Paliperidona(DOE),Etravirina(DOE),Daratumumab(DOE),Ibrutinib(DOE),Guselkumab(DOE),Asociación Darunavir/Cobicistat(DOE),Selexipag(DOE),Lazertinib(DOE) Y Amivantamab(DOE)
Spain – Pharmaceutical products – Suministro de Alectinib (DOE), Atezolizumab (DOE), Cobimetinib (DOE), Dornasa alfa (DOE), Pertuzumab (DOE), Polatuzumab vedotina (DOE), Rituximab (DOE) subcutáneo, Vemurafenib (DOE) y Vismodegib (DOE)
Spain – Pharmaceutical products – Suministro del medicamento DAUNORUBICINA Y CITARABINA (DOE) para todas las organizaciones de servicios de Osakidetza y centros vinculados
Spain – Pharmaceutical products – Suministro de Cabotegravir (DOE) para profilaxis preexposición del VIH1
Spain – Pharmaceutical products – Suministro de Emicizumab (DOE) y Risdiplam (DOE)
Spain – Pharmaceutical products – CONTR 2026 200980 CBAM-1 GRANADA AMC 2204-2025 (578/2025) MEDICAMENTOS EXCLUSIVOS
Spain – Pharmaceutical products – Suministro de contrastes iodados no iónicos Iomeprol (DOE) e Iopamidol (DOE) y sus sistemas de administración (bombas de infusión y material fungible complementario necesario para la administración)
Spain – Pharmaceutical products – Suministro de Interferon Beta1B (DOE), Levonorgestrel (DOE) SLI 52 mg, Tadalafilo (DOE), Efavirenz (DOE), Valganciclovir (DOE), Busulfano (DOE), Bortezomib (Doe), Metadona (DOE) y Fibrinógeno (DOE)

See every Spain Pharmaceuticals opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Spain Pharmaceuticals intelligence report in your inbox

A personalized report on Spain Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.